Abstract |
Intraocular inflammatory disease, or uveitis, is a disorder that mostly affects children and young adults. It is the cause of about 10% of the severe visual handicap in the United States. Many of the severe, sight-threatening uveitic conditions are thought to be driven by putative autoimmune mechanisms, often with high-dose oral prednisone use as treatment, along with cytotoxic agents, antimetabolites, and cyclosporine adjunctively. The feeding of the uveitogenic retinal S-Ag to rats immunized with the same antigen resulted in clinical protection. A pilot study in which two patients, one with pars planitis and the other with Behcet's disease, were fed with the retinal S-Ag resulted in these patients' immunosuppressive medication being decreased and/or stopped. The trial also provided us with information concerning dosage and expected immune responses. A randomized, masked study looking at the effect of feeding retinal antigens to uveitis patients is ongoing.
|
Authors | R B Nussenblatt, S M Whitcup, M D de Smet, R R Caspi, A T Kozhich, H L Weiner, B Vistica, I Gery |
Journal | Annals of the New York Academy of Sciences
(Ann N Y Acad Sci)
Vol. 778
Pg. 325-37
(Feb 13 1996)
ISSN: 0077-8923 [Print] United States |
PMID | 8610986
(Publication Type: Journal Article, Review)
|
Chemical References |
- Antigens
- Arrestin
- Autoantigens
- Eye Proteins
|
Topics |
- Administration, Oral
- Adult
- Animals
- Antigens
(administration & dosage, immunology)
- Arrestin
- Autoantigens
(administration & dosage, immunology)
- CD8-Positive T-Lymphocytes
(immunology)
- Cells, Cultured
- Child
- Clinical Trials as Topic
- Eye Proteins
(administration & dosage, immunology)
- Humans
- Immune Tolerance
- Lymph Nodes
(immunology)
- Lymphocyte Activation
- Mice
- Pilot Projects
- Rats
- Rats, Inbred Lew
- Uveitis
(immunology, prevention & control, therapy)
|